HomeTBPH • NASDAQ
Theravance Biopharma Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 15.39M | 6.10% |
Operating expense | 28.75M | 18.59% |
Net income | -13.58M | -16.42% |
Net profit margin | -88.24 | -9.72% |
Earnings per share | -0.17 | -84.27% |
EBITDA | -14.02M | -30.13% |
Effective tax rate | 3.95% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 130.86M | 30.89% |
Total assets | 343.58M | -7.47% |
Total liabilities | 177.60M | 6.71% |
Total equity | 165.98M | — |
Shares outstanding | 50.00M | — |
Price to book | 3.32 | — |
Return on assets | -10.34% | — |
Return on capital | -16.42% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -13.58M | -16.42% |
Cash from operations | 43.04M | 4,311.25% |
Cash from investing | 30.63M | 79.89% |
Cash from financing | -854.00K | 50.23% |
Net change in cash | 72.82M | 409.57% |
Free cash flow | 49.46M | 1,651.21% |
Previous close
$11.01
Day range
$10.95 - $10.95
Year range
$7.44 - $11.82
Market cap
547.51M USD
Avg Volume
342.95K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Website
Employees
97
